Concentrations of progesterone, a metabolite of PGF2α, prolactin, and luteinizing hormone during development of idiopathic persistent corpus luteum in mares.
Abstract: In experiment 1, daily blood samples were available from Days 0 to 20 (Day 0 = ovulation) in mares with an interovulatory interval (IOI, n = 5) and in mares that developed idiopathic persistent corpus luteum (PCL, n = 5). The PCL was confirmed by maintenance of progesterone (P4) concentration until end of the experiment (Day 20). Significant interactions of group and day revealed the novel findings that luteinizing hormone (LH) was lower (P < 0.05) in the PCL group than that in the IOI group on Days 0 to 4, and prolactin was lower (P < 0.05) on Days 1, 4, 6, and 7. In experiment 2, treatment with a gonadotropin-releasing hormone antagonist (n = 6) significantly reduced LH on Days 1 to 6 compared with the controls (n = 6) but did not support the hypothesis that low LH during the postovulatory period increases the frequency of PCL. In experiment 3, P4, PGFM (a PGF2α metabolite), and prolactin concentrations on Days 12 to 20 from 2 reported experiments were combined to increase the number of mares with an IOI (n = 11) or a PCL (n = 11). An abrupt and complete decrease in P4 (luteolysis) began on Day 13 in the IOI group compared with a gradual and partial P4 decline after Day 12 in the PCL group. Concentrations of PGFM and prolactin were lower (P < 0.05) in the PCL group than those in the IOI group on the day at the end of the most pronounced decrease in P4. The PCL mares were subgrouped into those with an abrupt but incomplete P4 decrease (partial luteolysis; n = 5) at the expected time and those without partial luteolysis (n = 6). There were no significant differences between the 2 subgroups in concentrations of PGFM and prolactin, but on a tentative basis (P < 0.10), the concentration of PGFM seemed more focused on the day of the most pronounced decrease in P4 in the subgroup with partial luteolysis. Results for PCL compared with IOI indicated (1) postovulatory LH and prolactin were lower, (2) treatment to reduce postovulatory LH did not increase the incidence, and (3) both PGFM and prolactin were lower on the day of the most pronounced decrease in P4.
Copyright © 2016 Elsevier Inc. All rights reserved.
Publication Date: 2015-12-28 PubMed ID: 26808976DOI: 10.1016/j.domaniend.2015.12.004Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The study explores the behavior of certain hormones during the development of persistent corpus luteum (PCL) in mares. The research included three experiments, looking at several hormones and their concentrations at different times after ovulation. The findings indicate that luteinizing hormone (LH) and prolactin are lower in mares developing PCL immediately after ovulation, while progesterone and a metabolite of PGF2α, tend to decrease much slower in comparison to normal horses.
Explaining the Experiments and their Results
- Experiment 1: The researchers began by taking daily blood samples from a group of normal mares (n=5) and a group that developed PCL (n=5). Measurements were taken starting from the day of ovulation (Day 0) to Day 20. Analyses of these samples showed that in the immediate post-ovulation period, the mares developing PCL had significantly lower levels of LH and prolactin compared to normal mares. This demonstrated the reduction of these hormones early in the process of PCL development.
- Experiment 2: The second experiment involved the administration of a gonadotropin-releasing hormone antagonist to some animals (n=6). This significantly reduced LH concentration during Days 1 to 6 compared to controls (n=6). But the results did not support the hypothesis that low LH levels in the post-ovulatory period increase the frequency of PCL, suggesting that some other factor might be influencing the development of PCL.
- Experiment 3: The third experiment combined data from previous studies to examine larger group of mares looking at levels of P4, PGFM (a metabolite of PGF2α), and prolactin between Days 12 and 20. The researchers found that progesterone (P4) fell abruptly in normal mares from Day 13 onwards, while in PCL mares the P4 decrease was gradual and partial. Additionally, PCL mares had lower concentrations of the PGFM and prolactin on the day when decrease in P4 was most pronounced. Further analysis revealed no significant differences in the concentrations of PGFM and prolactin between mares with partial luteolysis and those without.
Conclusions Drawn from the Experiments
- Post-ovulatory LH and prolactin were found to be lower in the mares suffering from PCL.
- Attempt to reduce post-ovulatory LH through treatment didn’t increase the incidence of PCL, suggesting that PCL occurrence isn’t simply a result of low LH concentrations.
- Both PGFM and prolactin were discovered to be lower in PCL mares on the day with the most pronounced P4 decrease, pointing towards an altered hormonal profile in the development and persistence of PCL.
Cite This Article
APA
Ginther OJ, Baldrighi JM, Castro T, Wolf CA, Santos VG.
(2015).
Concentrations of progesterone, a metabolite of PGF2α, prolactin, and luteinizing hormone during development of idiopathic persistent corpus luteum in mares.
Domest Anim Endocrinol, 55, 114-122.
https://doi.org/10.1016/j.domaniend.2015.12.004 Publication
Researcher Affiliations
- Eutheria Foundation, Cross Plains, WI 53528, USA; Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53706, USA. Electronic address: oginther@wisc.edu.
- Eutheria Foundation, Cross Plains, WI 53528, USA; Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53706, USA.
- Eutheria Foundation, Cross Plains, WI 53528, USA; Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53706, USA.
- Eutheria Foundation, Cross Plains, WI 53528, USA; Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53706, USA; CAPES Foundation, Ministry of Education of Brazil, Brasilia-DF, 70040-020, Brazil.
- Eutheria Foundation, Cross Plains, WI 53528, USA; Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53706, USA.
MeSH Terms
- Animals
- Corpus Luteum / metabolism
- Dinoprost / analogs & derivatives
- Dinoprost / blood
- Dinoprost / metabolism
- Female
- Horse Diseases / blood
- Horses
- Luteinizing Hormone / blood
- Luteolysis / physiology
- Oligopeptides / pharmacology
- Ovulation / drug effects
- Ovulation / physiology
- Progesterone / blood
- Progesterone / metabolism
- Prolactin / blood
Citations
This article has been cited 1 times.- Pemayun TGO, Mustofa I, Mahaputra L, Hermadi HA, Wijaya NMR, Mulyati S, Utama S, Restiadi TI, Rimayanti R. Fertility restoration of racing mare with persistent corpus luteum.. Vet World 2021 Sep;14(9):2356-2361.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists